Business · 31/05/2018Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance on Assessing Blood Pressure Effects of New Drugs

The Food and Drug Administration (FDA) has released a draft guidance for industry titled "Assessment of Pressor Effects of Drugs," which advises sponsors on premarketing assessment of a drug's effect on blood pressure. This guidance aims to help the FDA evaluate the potential cardiovascular risks associated with a new medication.